Cheryl F. Lichti

Chemistry · Physical Sciences

29h-index5.3kcitations131works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Proteomics Techniques and Applications(51), Mass Spectrometry Techniques and Applications(46), Advanced biosensing and bioanalysis techniques(13), Diabetes and associated disorders(12), Monoclonal and Polyclonal Antibodies Research(11)

Publications130 total

A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform
Science·2026· 3 citedOpen Access
A microenvironment-driven HLA-II-associated insulin neoantigen elicits persistent memory T cell activation in diabetes
Nature Immunology·2025· 3 citedOpen Access
Itaconate modulates immune responses via inhibition of peroxiredoxin 5 2077
The Journal of Immunology·2025Open Access
A SWI/SNF-specific Ig-like domain, SWIFT, is a transcription factor binding platform
2025· 1 citedOpen Access
Massively parallel immunopeptidome by DNA sequencing provides insights into cancer antigen presentation
Nature Genetics·2025· 2 citedOpen Access
Itaconate modulates immune responses via inhibition of peroxiredoxin 5
Nature Metabolism·2025· 12 cited
A microenvironment-driven, HLA-II-associated insulin neoantigen elicits persistent memory T cell activation in diabetes
2024· 3 citedOpen Access
Endogenous self-peptides guard immune privilege of the central nervous system
Nature·2024· 38 citedOpen Access
Crinophagic granules in pancreatic β cells contribute to mouse autoimmune diabetes by diversifying pathogenic epitope repertoire
Nature Communications·2024· 11 citedOpen Access
Engineered T cell therapy for central nervous system injury
Nature·2024· 47 cited
Data from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Figure S5 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Table S5 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Table S2 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Tables S6-S9 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Table S2 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Figure S8 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Table S15 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Figure S2 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
Table S14 from Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Carol L. Nilsson(10), R. Reid Townsend(8), Emil R. Unanue(8), Xiaoxiao Wan(7), Norelle C. Wildburger(7), Ekaterina Mostovenko(7), Anthony N. Vomund(6), Fernanda Laezza(6), Alexander S. Shavkunov(5), Miroslav N. Nenov(5), Ákos Végvári(5), György Marko‐Varga(5), Thomas A. Green(5), Frederick F. Lang(5), Erik P. Sulman(5), Orion J. Peterson(4), Melinda Rezeli(4), Maxim N. Artyomov(3), Matthew R. Meyer(3), A. Zielińska(3)